Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER
Document Type and Number:
WIPO Patent Application WO/2023/008462
Kind Code:
A1
Abstract:
The present invention relates to a medicament for the treatment and/or prevention of cancer, the medicament being characterized by comprising an antibody having an immunological reactivity with CAPRIN-1 protein or a fragment of the antibody and an MAPK pathway inhibitor which are combined with each other in a blended or separated form.

Inventors:
WASAI UKEI (JP)
KUME MASAHIKO (JP)
OKANO FUMIYOSHI (JP)
SAITO TAKANORI (JP)
Application Number:
PCT/JP2022/028878
Publication Date:
February 02, 2023
Filing Date:
July 27, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TORAY INDUSTRIES (JP)
International Classes:
A61K39/395; A61K31/519; A61K45/00; A61P35/00; A61P35/02; A61P43/00; C07K16/28; C07K16/46; C12N15/13
Domestic Patent References:
WO2019189780A12019-10-03
WO2011096535A12011-08-11
WO2013125630A12013-08-29
WO2021182573A12021-09-16
WO2010016526A12010-02-11
WO2011096535A12011-08-11
WO2014012479A12014-01-23
WO1996002576A11996-02-01
WO1999051743A11999-10-14
WO2004063351A22004-07-29
WO2011120135A12011-10-06
WO2011005481A12011-01-13
WO2005063351A12005-07-14
WO2011096517A12011-08-11
WO2011096528A12011-08-11
WO2011096519A12011-08-11
WO2011096533A12011-08-11
WO2011096534A12011-08-11
WO2013018886A12013-02-07
WO2013018894A12013-02-07
WO2013018892A12013-02-07
WO2013018891A12013-02-07
WO2013018889A12013-02-07
WO2013018883A12013-02-07
WO2013125636A12013-08-29
WO2013125654A12013-08-29
WO2013125630A12013-08-29
WO2013125640A12013-08-29
WO2013147169A12013-10-03
WO2013147176A12013-10-03
WO2015020212A12015-02-12
WO2021120890A12021-06-24
WO2022017519A12022-01-27
WO2019122129A12019-06-27
WO2021228028A12021-11-18
WO2021203768A12021-10-14
WO2022017339A12022-01-27
WO2022028506A12022-02-10
WO2015054572A12015-04-16
WO2021118877A12021-06-17
WO2018143315A12018-08-09
WO2019110751A12019-06-13
WO2019110751A12019-06-13
WO2021219090A12021-11-04
WO2021219072A12021-11-04
WO2021218939A12021-11-04
WO2021216770A12021-10-28
WO2021109737A12021-06-10
WO2021113595A12021-06-10
WO2021252339A12021-12-16
WO2021252339A12021-12-16
WO2021244603A12021-12-09
WO2021239058A12021-12-02
WO2021121367A12021-06-24
WO2018143315A12018-08-09
WO2021129820A12021-07-01
WO2019099524A12019-05-23
WO2020233592A12020-11-26
WO2021129824A12021-07-01
WO2020146613A12020-07-16
WO2021108683A12021-06-03
WO2022042630A12022-03-03
WO2022002102A12022-01-06
WO2021107160A12021-06-03
WO2021005165A12021-01-14
WO2017087528A12017-05-26
WO2021116055A12021-06-17
WO2011103196A12011-08-25
WO2011090738A22011-07-28
WO2021110141A12021-06-10
WO2019107987A12019-06-06
WO2015075483A12015-05-28
WO2017080979A12017-05-18
WO2020238776A12020-12-03
WO2021063335A12021-04-08
WO2021110168A12021-06-10
WO2021218912A12021-11-04
Foreign References:
JP2015502958A2015-01-29
JP2021122072A2021-08-26
EP0239400A21987-09-30
US8388955B22013-03-05
US6737056B12004-05-18
US6602684B12003-08-05
EP1914244A22008-04-23
US7579170B22009-08-25
US8642292B22014-02-04
US20180072723A12018-03-15
US20180072723A12018-03-15
CN112694475A2021-04-23
CN113563323A2021-10-29
CN112920183A2021-06-08
EP1003721B12006-11-02
CH5126766A4
ZM336372A
Other References:
NOBUYA ISHII: "MEK/RAF, big names in cancer molecular targeting Research and development of MAPK pathway inhibitors", FOLIA PHARMACOL. JPN, vol. 141, 1 January 2013 (2013-01-01), pages 15 - 21, XP093028692
LIU FEN, JIANG CHEN CHEN, YAN XU GUANG, TSENG HSIN-YI, WANG CHUN YAN, ZHANG YUAN YUAN, YARI HAMED, LA TING, FARRELLY MARGARET, GUO: "BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma", ONCOTARGET, vol. 8, no. 41, 19 September 2017 (2017-09-19), pages 69477 - 69492, XP093028696, DOI: 10.18632/oncotarget.17704
J. HEMATOL. ONCOL., vol. 17, no. 13, 2020, pages 113
BIOL CELL., vol. 93, no. 1-2, 2001, pages 53 - 62
INT. J. MOL. SCI., vol. 21, no. 3, 2020, pages 1102
NAT MED., vol. 19, no. 11, 2013, pages 1401 - 9
KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5877
ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402
SATO K. ET AL., CANCER RESEARCH, vol. 53, 1993, pages 851 - 856
KOHLER, G.MILSTEIN, C, METHODS ENZYMOL., vol. 73, 1981, pages 3 - 46
BIOCHIM BIOPHYS ACTA., vol. 1773, no. 8, 2007, pages 1263 - 84
Attorney, Agent or Firm:
HIRAKI & ASSOCIATES (JP)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

Next Patent: NEUTRALIZING HUMAN ANTIBODY AGAINST WILD TYPE STRAIN AND MUTANT STRAIN OF SARS-COV-2 AND ANTIGEN-BIN...